Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype

OBJECTIVE—Pharmacogenomics is a key component of personalized medicine. The Israel Cardiovascular Events Reduction with Vitamin E Study, a prospective placebo-controlled study, recently demonstrated that vitamin E could dramatically reduce CVD in individuals with diabetes and the haptoglobin (Hp) 2-...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Asleh, Rabea, Blum, Shany, Kalet-Litman, Shiri, Alshiek, Jonia, Miller-Lotan, Rachel, Asaf, Roy, Rock, Wasseem, Aviram, Michael, Milman, Uzi, Shapira, Chen, Abassi, Zaid, Levy, Andrew P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Diabetes Association 2008
Aiheet:
Complications
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2551691/
https://ncbi.nlm.nih.gov/pubmed/18599520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db08-0450
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia